electroCore
ECOR | NASDAQ
$4.84
-$0.41 (-7.81%)
At close: Nov 16, 2026, 4:00 PM ET
$4.90
+$0.06 (+1.24%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-7.81%
(1D)No price chart data available for 1D timeframe.
Rating
50.8
+3.0 ptsFundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #267/1021 (Top 26%)
Key Statistics
Market Data
Market Cap $48.18M
1D Range
4.73 5.75
52W Range
4.42 12.29
Valuation (TTM)
PE -3.38
PB -19.21
EV/EBITDA -4.79
Valuation (NTM)
Forward PE 78.80
Forward PEG 0.12
Price Target $18.00
Cash Flow
FCF Yield -22.6%
SBC Adj. FCF Yield -28.6%
SBC Impact -26.4%
Margins
Gross Margin 87.7%
Operating Margin -33.1%
FCF Margin -28.7%
Growth (CAGR)
Revenue 3Y | 5Y 41.5% |
50.7%
Dil EPS 3Y | 5Y 12.0% |
31.3%
FCF 3Y | 5Y -11.1% |
16.5%
Returns
ROA -73.6%
ROE 498.8%
ROIC -170.0%
Financial Health
Net Cash
$607K
Current Ratio 1.34
Interest Coverage -9.44
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, t...
Sector Healthcare
Industry Medical - Devices
Employees 83
IPO Date Jun 22, 2018
Website www.electrocore.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 4, 2026
EPS
-$0.13
Beat +52.21%
YoY:
+67.50% REV
$9.69M
Miss -11.30%
YoY:
+11.52%Next Earnings
Mar 18, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$18.00
Upside
+271.90%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ECOR